Sophia Genetics Raises FY2026 Sales Guidance from $92.000M-$94.000M to $94.000M-$96.000M vs $93.403M Est
Sophia Genetics (NASDAQ: SOPH ) raises FY2026 sales outlook from $92.000 million-$94.000 million to $94.000 million-$96.000 million vs $93.403 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.